Stockreport

Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News? [Yahoo! Finance]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF mark a milestone for the business and lead to significant revenue growth. The risk with many biotech stocks is not knowing if they will obtain approval for a key treatme [Read more]